- Background
- What we're looking for
- What we can offer you
- Who we are
- Q&A
Are you ready to amplify your impact and expand into the U.S.? The Boston-Cambridge ecosystem—home to Bayer Co.Lab Cambridge—leads the world in biotech innovation, offering unparalleled opportunities to scale and thrive.
Background
Strategic partner:
Sponsored by:
While Europe is a center for pharmaceutical innovation, the United States stands out as the sole market that can sustain that innovation. Accessing this market influences funding, culture, talent, and reputation, but is often constrained by know-how and personal networks. Bayer Pharmaceuticals is launching the ‘Bayer Co.Lab Connect’ program to support one early-stage startup in expanding their presence in the U.S. while building a relationship with Bayer.
Bayer Co.Lab is partnering Switzerland’s No.1 laboratory provider, Superlab Suisse, and with the support of world-class innovation players like Curie.Bio, Goodwin, and Danforth Advisors. Co.Lab Connect Basel is creating a pathway to the Boston-Cambridge ecosystem by providing Swiss biotech entrepreneurs and startups direct access to top-notch laboratory and office space, as well as valuable expertise and mentoring tailored for the U.S. market. Bayer Co.Lab will select one company that will receive a travel grant to attend Bayer's exclusive event in Boston during BIO International 2025.
The selected startup will be included in the Bayer Co.Lab portfolio and will receive early endorsement of their scientific projects, connections to vetted venture capital networks, insights into the legal requirements for establishing a U.S. presence, and scientific guidance during the span of one year. While establishing a U.S. presence is an option, participation in the program does not require relocation. Startups will receive resources and connections even if they choose to remain in their home country.
Bayer Co.Lab Connect is your gateway to the Boston-Cambridge ecosystem. We provide non-U.S. startups with the tools, networks, and resources needed to establish a foothold in the U.S. from Bayer Co.Lab Cambridge, situated in the most innovative square mile on the planet, and to achieve sustainable growth with Bayer’s expertise and support.
What we're looking for
- Precision oncology: small molecules, biologics, RNA targeting therapy, and radiopharmaceuticals, preferably targeting solid tumors or linked to biomarkers or genetical alterations leading to better efficacy or safety
- Precision cardiology or precision nephrology: any modalities, with a preference for strong linkage to the biomarkers or genetical alterations leading to better efficacy or safety
- Tissue targeting solutions: novel targets, AAV- or nanoparticle-based tissue targeting solutions
- CNS and aging-related diseases: cell and gene therapy as preferred modality
- Immunology: small molecules and biologics, preferably with strong evidence linking them to a specific medical condition or disease
- Switzerland
- Germany
- France
- Italy
- Austria
- Pre-seed
- Seed
- Series A
Bayer Co.Lab is Bayer’s global network of life science incubators designed to foster early engagement with innovative technologies. Our mission is to provide entrepreneurs and early-stage companies with unparalleled access to expertise, resources, and cutting-edge facilities, all without any obligations. At Co.Lab, we pride ourselves on a personalized, high-touch approach to supporting our resident companies.
Our flagship U.S. location, Co.Lab Cambridge, is strategically situated alongside Bayer’s Oncology, Cardiovascular, and Nephrology R&D teams, as well as Bayer’s affiliate iPSCs company, BlueRock Therapeutics. Our incubator place resides within the newly established Bayer Research & Innovation Center, located in the heart of Kendall Square, Cambridge, USA—the global epicenter for biotechnology.
In addition to our U.S. presence, Co.Lab has expanded its global reach to include three additional locations in Berlin, Shanghai, and Kobe, further enhancing our commitment to supporting life science innovation worldwide.
The Q&A is now closed.
In-Person Locations
Cambridge, Massachusetts, USA
delivered to your inbox.